1233 related articles for article (PubMed ID: 31295952)
1. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
Bunte K; Beikler T
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
[TBL] [Abstract][Full Text] [Related]
3. The pathogenicity of Th17 cells in autoimmune diseases.
Yasuda K; Takeuchi Y; Hirota K
Semin Immunopathol; 2019 May; 41(3):283-297. PubMed ID: 30891627
[TBL] [Abstract][Full Text] [Related]
4. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases.
Qu N; Xu M; Mizoguchi I; Furusawa J; Kaneko K; Watanabe K; Mizuguchi J; Itoh M; Kawakami Y; Yoshimoto T
Clin Dev Immunol; 2013; 2013():968549. PubMed ID: 23956763
[TBL] [Abstract][Full Text] [Related]
5. Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview.
Schinocca C; Rizzo C; Fasano S; Grasso G; La Barbera L; Ciccia F; Guggino G
Front Immunol; 2021; 12():637829. PubMed ID: 33692806
[TBL] [Abstract][Full Text] [Related]
6. The IL-23/IL-17 pathway in inflammatory bowel disease.
Geremia A; Jewell DP
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):223-37. PubMed ID: 22375527
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic benefits of regulating inflammation in autoimmunity.
Nikoopour E; Schwartz JA; Singh B
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
[TBL] [Abstract][Full Text] [Related]
8. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
Maddur MS; Miossec P; Kaveri SV; Bayry J
Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
[TBL] [Abstract][Full Text] [Related]
9. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
[TBL] [Abstract][Full Text] [Related]
10. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
Bellinger DL; Lorton D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
[TBL] [Abstract][Full Text] [Related]
11. Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B.
Huang Z; van Velkinburgh JC; Ni B; Wu Y
Liver Int; 2012 Jul; 32(6):894-901. PubMed ID: 22340646
[TBL] [Abstract][Full Text] [Related]
12. Th17 cells in immunity and autoimmunity.
Bedoya SK; Lam B; Lau K; Larkin J
Clin Dev Immunol; 2013; 2013():986789. PubMed ID: 24454481
[TBL] [Abstract][Full Text] [Related]
13. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited.
Boniface K; Blom B; Liu YJ; de Waal Malefyt R
Immunol Rev; 2008 Dec; 226():132-46. PubMed ID: 19161421
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Interleukin-17 Production.
Dong W; Ma X
Adv Exp Med Biol; 2016; 941():139-166. PubMed ID: 27734412
[TBL] [Abstract][Full Text] [Related]
15. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
[TBL] [Abstract][Full Text] [Related]
17. Interluekin-17A (IL17A).
Chen K; Kolls JK
Gene; 2017 May; 614():8-14. PubMed ID: 28122268
[TBL] [Abstract][Full Text] [Related]
18. IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
Furfaro F; Gilardi D; Allocca M; Cicerone C; Correale C; Fiorino G; Danese S
Expert Rev Clin Immunol; 2017 May; 13(5):457-467. PubMed ID: 28067059
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
Lovato P; Norsgaard H; Tokura Y; Røpke MA
J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
[TBL] [Abstract][Full Text] [Related]
20. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
